Breast cancer and fertility: Critical review, considerations and perspectives;Cancer du sein et fertilité: Revue critique, réflexions et perspectives

Bulletin du Cancer

Volumn 95, Issue 1, 2008, Pages 17-25

  This, Pascale ^a,b  

^a INSTITUT CURIE   (France)

^b CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

Breast cancer; Fertility; Fertility preservation; In vitro fertilization; Oocyte donation

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GONADORELIN ANTAGONIST; TAMOXIFEN; ANTINEOPLASTIC AGENT; FERTILITY PROMOTING AGENT; GONADORELIN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CRYOPRESERVATION; DIAGNOSTIC ACCURACY; EXPERIMENTAL STUDY; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL REGULATION; HUMAN; MEDICAL SPECIALIST; ONCOLOGY; OOCYTE; OOCYTE DONATION; OVARY; OVARY FUNCTION; OVARY INSUFFICIENCY; PHYSICIAN; PRESCRIPTION; REVIEW; ADULT; AMENORRHEA; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG POTENTIATION; EMBRYO TRANSFER; FEMALE; FERTILITY; INFERTILITY THERAPY; METHODOLOGY; OVULATION INDUCTION; PATHOPHYSIOLOGY; PATIENT EDUCATION; PREGNANCY; TISSUE PRESERVATION;

ADULT; AMENORRHEA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FERTILITY; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; OOCYTES; OVARY; OVULATION INDUCTION; PATIENT EDUCATION AS TOPIC; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; TAMOXIFEN; TISSUE PRESERVATION;

EID: 39149142584     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2007.0496     Document Type: Review

References (45)

1. Goodwin. P, Ennis M, Pritchard K, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999 ; 17 : 2365-70.
2. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996 ; 14 : 1718-29.
3. Lee S, Schover L, Partridge A, Patrizio P, Wallace W, Hagerty K, et al. American Society of Clinical Oncology recommandations on fertility preservation in cancer patients. J Clin Oncol 2006 ; 24 : 2917-31.
4. Petrek J, Naughton M, Case L, Paskett E, Naftalis E, Singletary S, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment : a prospective study. J Clin Oncol 2006 ; 24 : 1045-51.
5. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on reccurence and 15 year survival : an overview of the randomized trials. Lancet 2005 ; 365 : 1687-717.
6. Darbre P, Curtis S, King R. Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. Cancer Res 1984 ; 44 : 2790-3.
7. Iino Y, Wolf D, Langan-Fahey S, Johnson D, Ricchio M, Thompson M, et al. Reversible control of oestradiol-stimulated growth of MCF7 tumours by tamoxifen in the arhymic mouse. Br J Cancer 1991 ; 64 : 1019-24.
8. Gerhard I, Runnebaum B. Comparison between tamoxifen and clomiphene therapy in women with anovulation. Arch Gynecol 1979 ; 227 : 279-88.
9. Barthelmes L, Gateley C. Tamoxifen and pregnancy. Breast 2004 ; 13 : 446-51.
10. Thewes B, Meiser B, Taylor A, Phillips K, Pendlebury S, Capp A, et al. Fertility and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 2005 ; 23 : 5155-65.
11. Duffy C, Allen S, Clark M. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 2005 ; 23 : 766-73.
12. Partridge A, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004 ; 22 : 4174-83.
13. Serin D, Dilhuydy J, Guiochet N, Romestaing P, Gledhill J, Bret P, et al. Parcours de femme 2001, enquête française sur la prise en charge er les besoins des patientes atteintes de cancer du sein ou gynécologique : ce qui a changé de 1993 à 2001. Bull Cancer 2005 ; 92 : 817-27.
14. Sonmezer M. KOktay. Fertility preservation in young women undergoing breast cancer therapy. Oncologist 2006 ; 11 : 422-34.
15. Kim S. Fertility preservation in female cancer patients : current developments and future directions. Fertil Steril 2006 ; 85 : 1-11.
16. Frydman N, Hesters L, Fanchin R. Fécondation in vitro : aspects cliniques et biologiques. Rev Prat 2006 ; 56 : 507-12.
17. Olivennes F, Aubard Y. Traitement du cancer chez la femme et préservation de la fertilité. Bull Cancer 2002 ; 89 : 786-94.
18. Oktay K, Buyuk E, Davis O, Yermakova I, Veek L, Rosenwaks Z. Fertility preservation in breast cancer patients : IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003 ; 18 : 90-5.
19. Oktay K, Buryuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients : a prospective controlled comparison of ovarian stimulation with tamoxifen, and letrozole for embryo cryopreservation. J Clin Oncol 2005 ; 19 : 4347-53.
20. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006 ; 91 : 3885-90.
21. DeZiegler D, Mattenberger C, Luyet C, Romoscanu I, Irion NF, Bianchi-Demichelli F. Clinical use of aromatase inhibitors in premenopausal women. J Steroid Biochem Mol Biol 2005 ; 95 : 121-7.
22. Partridge A, Winer E. Fertility after breast cancer : questions abound. J Clin Oncol 2005 ; 19 : 4259-61.
23. Smith I, Dowsett M, Yap Y, Walsh G, Lonning P, Santen R, et al. Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhea : caution and suggested guidelines. J Clin Oncol 2006 ; 24 : 2444-7.
24. Biljan M, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 2005 ; 84(supp 1) ; (abstract 1033).
25. Tulandi T, Martin J, Alfadhli R, Kabli N, Forman R, Hitkari J, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006 ; 85 : 1761-5.
26. Oktay K, Cil A, Bang H. Efficiency of oocyte cryopreservation : a meta-analysis. Fertil Steril 2006 ; 86 : 70-80.
27. Donnez J, Dolmans M, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004 ; 364 : 1405-10.
28. Meirow D, Levron J, Eldar-Geva T. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005 ; 353 : 320-1.
29. Courbière B, Porcu G, Saias-Magnan J, Guillemain C, Noizet A, Michel G, et al. Cryoconservation ovarienne : problèmes cliniques et éthiques. A propos d'une série de cas d'autoconservation de tissu ovarien. Gynecol Obstet Fertil 2006 ; 34 : 607-14.
30. Blumenfeld Z, Eckman A. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRHa. J Natl Cancer Inst 2005 ; 34 : 40-3.
31. Fenichel P. Peut-on préserver médicalement la fonction ovarienne avant et pendant la radiochimiothérapie? Gynecol Obstet Fertil 2005 ; 33 : 610-4.
32. Recchia F, Saggio G, Amiconi G, Basio AD, Cesta A, Candeloro G, et al. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 2006 ; 106 : 514-23.
33. Delmastro L, Catzeddu T, Boni L, Bell C, Sertoli M, Bighin C, et al. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young breast cancer patients. Ann Oncol 2006 ; 17 : 74-8.
34. Wildiers H, Neven P, Amant F. D'hooghe T, Paridaens R. Fertility preservation in (breast) cancer patients : Is it safe? J Clin Oncol 2006 ; 24 : 5335-6.
35. Delmastro L. Fertility preservation strategies for breast cancer patients. J Clin Oncol 2006 : 4220-1.
36. Delmastro L, Catzeddu T, Venturini M. Infertility and pregnancy after breast cancer : current knowledge and future perspectives. Cancer Treat Rev 2006 ; 32 : 417-22.
37. Park M, Davidson R, Fox K. Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancer. Semin Oncol 2006 ; 33 : 664-71.
38. Fivnat, Belaisch-Allart J, Devaux A, Ayel J, Mouzon JD. La femme de 40 ans et plus en FIV et en ICSI : données Fivnat. Gynecol Obstet Fertil 2004 ; 32 : 730-6.
39. Gervaise A, Fernandez H. Le drilling ovarien dans le traitement des ovaires polykystiques. Gynecol Obstet Fertil 2005 ; 33 : 713-7.
40. Pelinck M, Vogel N, Hoek A, Arts E, Simons A, Heineman M. Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH : a pilot study. Hum Reprod 2005 ; 20 : 642-8.
41. Demouzon J, Allavena E, Schmitt C, Frappé M. La fécondation in vitro en France. Approche économique et influence du choix des gonadotrophines (urinaires ou recombinantes) sur le coût. Gynecol Obstet Fertil 2004 ; 32 : 508-18.
42. Letur-Konirsch H. Don d'ovocytes en France et bilan national (GEDO). Dispositions différentielles européennes. Gynecol Obstet Fertil 2004 ; 32 : 108-15.
43. Cohen J. Le tourisme procréatif : un pis-aller. Gynecol Obstet Fertil 2006 ; 34 : 881-2.
44. Moutel G. Don et accueil d'embryons : une évolution novatrice qui demeure sensible. La lettre du Gynécologue 2005 : 4-7.
45. Bettahar-lebugle K, Wittemer C, Firtion C, Rongières C, Ohl J, Nisand I, et al. L'accueil d'embryon en France : pratiques et difficultés. L'expérience de Strasbourg. Gynecol Obstet Fertil 2007 ; 35 : 114-20.